IONS — Ionis Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $13.42bn
- $13.84bn
- $943.71m
Ionis Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
U.S. STOCKS ON THE MOVE-Ionis Pharmaceuticals, Saia, Viatris
U.S. STOCKS ON THE MOVE-Janover, AMC Entertainment, U.S. Steel
H.C. Wainwright initiates coverage for Ionis Pharma with 'buy' rating citing pending drug launches
Brief: Ionis Expands Partnership With SOBI To Include Olezarsen Commercialization Outside The U.S.
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Beacon Roofing, Liberty Energy
Brief: Ionis And Ono Announce Global License Agreement For Sapablursen In Polycythemia Vera
Brief: WAINZUA (Eplontersen) Approved In The EU For The Treatment Of Hereditary Transthyretin-Mediated Amyloidosis In Adults With Stage 1 Or Stage 2 Polyneuropathy
Brief: New Positive Donidalorsen Data To Be Presented At Aaaai/Wao Joint Congress
U.S. STOCKS ON THE MOVE-Charles River Lab, Carvana, Materion
U.S. STOCKS ON THE MOVE-Travelers, Capri, Garmin
U.S. STOCKS ON THE MOVE-Bumble, Nikola, Diversified Energy
Ionis Pharma rises on better-than-expected quarterly results
Brief: Ionis Pharmaceuticals Q4 Revenue USD 227 Million Vs. IBES Estimate USD 137.6 Million
U.S. RESEARCH ROUNDUP-Hershey, Paychex, Revvity
U.S. STOCKS ON THE MOVE-Spire, Copper miners, Abercrombie & Fitch
U.S. STOCKS ON THE MOVE-Mission Produce, Sirius XM, Carnival Corp
U.S. STOCKS ON THE MOVE-Humacyte, Ionis Pharmaceuticals, Emeren Group
U.S. STOCKS ON THE MOVE-FedEx, Eli Lilly, Aadi Bioscience